Last reviewed · How we verify
Hyperici extractum oleosum vagitories
Hyperici extractum oleosum vagitories is a Small molecule drug developed by University of Sarajevo. It is currently FDA-approved.
At a glance
| Generic name | Hyperici extractum oleosum vagitories |
|---|---|
| Sponsor | University of Sarajevo |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Hyperici extractum oleosum vagitories CI brief — competitive landscape report
- Hyperici extractum oleosum vagitories updates RSS · CI watch RSS
- University of Sarajevo portfolio CI
Frequently asked questions about Hyperici extractum oleosum vagitories
What is Hyperici extractum oleosum vagitories?
Hyperici extractum oleosum vagitories is a Small molecule drug developed by University of Sarajevo.
Who makes Hyperici extractum oleosum vagitories?
Hyperici extractum oleosum vagitories is developed and marketed by University of Sarajevo (see full University of Sarajevo pipeline at /company/university-of-sarajevo).
What development phase is Hyperici extractum oleosum vagitories in?
Hyperici extractum oleosum vagitories is FDA-approved (marketed).